Blockchain Registration Transaction Record

Lantern Pharma Expands predictBBB Platform into Large Quantitative Model

Lantern Pharma expands predictBBB into Large Quantitative Model (LQM) using RADR AI, enabling real-time molecular profiling from SMILES input to accelerate drug discovery.

This expansion matters because it democratizes access to advanced AI-driven drug discovery tools, enabling researchers worldwide to rapidly evaluate small molecules and potentially accelerate the development of new cancer therapies. By integrating molecular intelligence into a user-friendly web platform, Lantern Pharma is lowering barriers to computational drug design, which could lead to faster identification of promising drug candidates and more efficient use of resources in oncology R&D.